PENICILLAMINE
Tracking # 20-1058520
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
PENICILLAMINE HAS FDA APPROVAL AS A TREATMENT FOR WILSON DISEASE AND CYSTINURIA. IT IS USED AS AN OFF-LABEL TREATMENT OPTION FOR LEAD POISONING IN CHILDREN. IT IS CONSIDERED A CONVENTIONAL DISEASE-MODIFYING ANTIRHEUMATIC DRUG (DMARD). THIS ACTIVITY PRESENTS PENICILLAMINE'S INDICATIONS, CONTRAINDICATIONS, AND SIDE EFFECTS AND HIGHLIGHTS THE INTERPROFESSIONAL TEAM'S ROLE IN MANAGING PATIENTS WITH WILSON DISEASE AND LEAD POISONING.
Subject areas
This course counts toward the state boards and subject areas below.
Bahamas Medical Council
Specialty Medical Practitioner
1h
General Medicine
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1h
Category I CME
Mississippi State Board of Medical Licensure
Medical Doctor
1h
AMA Category I
Physician Assistant
1h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1h
AMA Category I